Cargando…
AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection
Prior authorization (PA) and step therapy (ST) are utilization management tools that have been in use by managed care organizations for decades. These processes require that health care providers obtain advanced approval to qualify a specific product for coverage from a health plan before it is deli...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391120/ https://www.ncbi.nlm.nih.gov/pubmed/31880226 http://dx.doi.org/10.18553/jmcp.2020.26.1.55 |
_version_ | 1785082631058096128 |
---|---|
collection | PubMed |
description | Prior authorization (PA) and step therapy (ST) are utilization management tools that have been in use by managed care organizations for decades. These processes require that health care providers obtain advanced approval to qualify a specific product for coverage from a health plan before it is delivered to the patient. These tools are intended to ensure that patients have access to evidence-based medications while payers remain good stewards of limited health care resources. PA and ST are growing in use to support appropriate use of medications and manage associated costs but may pose challenges related to administrative burden and access to care. In June 2019, the Academy of Managed Care Pharmacy (AMCP) conducted a multistakeholder forum to identify processes for optimizing PA and ST utilization management programs. Health care leaders representing academia, health plans, integrated delivery systems, pharmacy benefit managers, employers, federal government agencies, national health care provider organizations, and patient advocacy organizations participated in the forum. Participants explored current operations of these programs, evaluated stakeholder perspectives on opportunities to improve these programs, and provided recommendations for next steps. They also reviewed current federal and state legislative and regulatory activities to reform PA and ST processes and offered guidance to support program improvements. The goal of the forum was to gather stakeholder input to inform the development of recommendations to improve efficiencies around PA and ST processes; provide recommendations to address administrative burdens; increase the visibility of the clinical and economic value of PA and ST utilization management programs; collect, review, and disseminate data-driven, real-world experiences of PA programs that support clinical and economic value; collect and disseminate best practices around PA appeals and denial processes; and improve channels of communications between health insurance providers, health care professionals, and patients to minimize care delays and improve clarity of coverage authorization requirements. |
format | Online Article Text |
id | pubmed-10391120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103911202023-08-02 AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection J Manag Care Spec Pharm Proceedings Prior authorization (PA) and step therapy (ST) are utilization management tools that have been in use by managed care organizations for decades. These processes require that health care providers obtain advanced approval to qualify a specific product for coverage from a health plan before it is delivered to the patient. These tools are intended to ensure that patients have access to evidence-based medications while payers remain good stewards of limited health care resources. PA and ST are growing in use to support appropriate use of medications and manage associated costs but may pose challenges related to administrative burden and access to care. In June 2019, the Academy of Managed Care Pharmacy (AMCP) conducted a multistakeholder forum to identify processes for optimizing PA and ST utilization management programs. Health care leaders representing academia, health plans, integrated delivery systems, pharmacy benefit managers, employers, federal government agencies, national health care provider organizations, and patient advocacy organizations participated in the forum. Participants explored current operations of these programs, evaluated stakeholder perspectives on opportunities to improve these programs, and provided recommendations for next steps. They also reviewed current federal and state legislative and regulatory activities to reform PA and ST processes and offered guidance to support program improvements. The goal of the forum was to gather stakeholder input to inform the development of recommendations to improve efficiencies around PA and ST processes; provide recommendations to address administrative burdens; increase the visibility of the clinical and economic value of PA and ST utilization management programs; collect, review, and disseminate data-driven, real-world experiences of PA programs that support clinical and economic value; collect and disseminate best practices around PA appeals and denial processes; and improve channels of communications between health insurance providers, health care professionals, and patients to minimize care delays and improve clarity of coverage authorization requirements. Academy of Managed Care Pharmacy 2020-01 /pmc/articles/PMC10391120/ /pubmed/31880226 http://dx.doi.org/10.18553/jmcp.2020.26.1.55 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Proceedings AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection |
title | AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection |
title_full | AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection |
title_fullStr | AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection |
title_full_unstemmed | AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection |
title_short | AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection |
title_sort | amcp partnership forum: optimizing prior authorization for appropriate medication selection |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391120/ https://www.ncbi.nlm.nih.gov/pubmed/31880226 http://dx.doi.org/10.18553/jmcp.2020.26.1.55 |